-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-143-section-5a-evidence-table.pdf
January 01, 2014 - Table 5.A.1. Evidence Table
…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-243-fullreport.pdf
August 01, 2019 - Overuse of Imaging: Policy for ALARA Specific to Imaging Children
Overuse of Imaging: Policy for ALARA Specific to
Imaging Children
Section 1. Basic Measure Information
1.A. Measure Name
Overuse of Imaging: Policy for ALARA Specific to Imaging Children
1.B. Measure Number
0243
1.C. Measure Description
…
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/diabetes-mellitus-screening-1996
January 01, 1996 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
archived
Final Recommendation Statement
Abnormal Blood Glucose and Type 2 Diabetes Mellitus: Screening, 1996
January 01, 1996
Recommendations made by the USPSTF are ind…
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/ZTMgupsEkCUuuPVpeGUm45
September 01, 2013 - Screening for Hepatitis C Virus Infection in Adults: U.S. Preventive
Services Task Force Recommendation Statement
Virginia A. Moyer, MD, MPH, on behalf of the U.S. Preventive Services Task Force*
Description: Update of the 2004 U.S. Preventive Services Task
Force (USPSTF) recommendation on screening for and treatment …
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/QWUmLEKdwcYA-AKGp5dNaQ
August 09, 2016 - untitled
Copyright 2016 American Medical Association. All rights reserved.
Screening for Lipid Disorders in Children and Adolescents
US Preventive Services Task Force
Recommendation Statement
US Preventive Services Task Force
T he US Preventive Services Task Force (USPSTF) makes rec-
ommendations about the effectiv…
-
digital.ahrq.gov/sites/default/files/docs/citation/r18hs025943-snyder-final-report-2024.pdf
January 01, 2024 - An Evaluation of the Spread and Scale of PatientToc™ from Primary Care to Community Pharmacy Practice for the Collection of Patient-Reported Outcomes - Final Report
1
An Evaluation of the Spread and Scale of PatientToc™ from Primary Care to Community
Pharmacy Practice for the Collection of Patient-Reported Outco…
-
digital.ahrq.gov/sites/default/files/docs/citation/r21hs025005-snyder-final-report-2019.pdf
January 01, 2019 - Enhancing Clinical Decision Support Applications for Community Pharmacist-Delivered Medication Therapy Management - Final Report
1
Enhancing Clinical Decision Support Applications for Community Pharmacist-Delivered
Medication Therapy Management
Final Report
Principal Investigator: Margie E. Snyder, Ph…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-218-osteoporosis-disposition-comments.pdf
April 23, 2019 - CER 218 Disposition of Comments: Long-Term Drug Therapy and Drug Holidays for Osteoporosis Fracture Prevention
Comparative Effectiveness Review Disposition of Public Reviewer Comments
Report
Research Review Title: Long-term Drug Therapy and Drug Holidays for Osteoporosis
Fracture Prevention: A Systematic Review
…
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/drug-use-illicit-screening
June 09, 2020 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
Final Recommendation Statement
Unhealthy Drug Use: Screening
June 09, 2020
Recommendations made by the USPSTF are independent of the U.S. government. They should not b…
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/hospital/qitoolkit/combined/b4_combo_documentationcoding.pdf
March 15, 2016 - Documentation and Coding for Patient Safety Indicators
Toolkit for Using the AHRQ Quality Indicators
How To Improve Hospital Quality and Safety
Tool B.4 i
Documentation and Coding for the AHRQ Quality Indicators
Note: This tool was updated based on test software provided by AHRQ as of March 2016 (alpha
version…
-
hcup-us.ahrq.gov/reports/methods/2019-04.pdf
January 01, 2019 - MS2019-04
HCUP Method Series
Conducting County-Level Analyses With HCUP Data:
Approaches and Methodological Considerations.
Report #2019-04
Contact Information:
Healthcare Cost and Utilization Project (HCUP)
Agency for Healthcare Research and Quality
5600 Fishers Lane
Room 07W17B Mail Stop 7W25B
Ro…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/liver-cancer_disposition-comments.pdf
October 23, 2014 - Peer Reviewer
#3
Methods The statistical methods seem appropriate. Thank you. … Peer Reviewer
#7
Methods I am NOT a good person to comment on the appropriateness of statistical
-
www.ahrq.gov/sites/default/files/publications/files/hacrate2013_0.pdf
October 01, 2015 - Even with the
uncertainty inherent in our statistical extrapolations, it is clear that approximately … HCUP Statistical Brief #29.
-
meps.ahrq.gov/survey_comp/appendix_d_glossary.shtml
December 31, 2020 - It is widely used for reporting medical
procedures for insurance billing and statistical … DSM-V – Diagnostic and Statistical Manual of
Mental Disorders:
-
meps.ahrq.gov/survey_comp/appendix_d_glossary.pdf
December 31, 2020 - It is widely used for reporting medical procedures for insurance billing and
statistical purposes. … DSM-V – Diagnostic and Statistical Manual of Mental Disorders: A classification system
of mental disorders
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/febrile-infants-diagnosis-management_executive.pdf
March 01, 2012 - The degree of statistical heterogeneity was
examined graphically by plotting values of sensitivity and
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-end-of-life-quality-meaures_research.pdf
April 01, 2010 - SAS for
Windows software (release 9.2) was used for all statistical analyses (The SAS Institute, Cary
-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/making-healthcare-safer/mhs3/anticoagulants-1.pdf
March 01, 2020 - No statistical significance
examined.
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/MzHhsgTBL37rRvvJfkfgMZ
August 20, 2019 - estimates, study limitations, risk of reporting bias, and applica-
bility, and summarized in a table.36 No statistical … International Breast Cancer Interven-
tion Study (IBIS) risk model, and brief versions of BRCAPRO, a com-
plex statistical
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/asthma-treatment-future_research.pdf
September 01, 2012 - Food
and Drug Administration Medical and Statistical Reviews), clinical trial registries (e.g., National